Centro de Investigación Científica y de Educación Superior de Ensenada, Baja California
Año
Autores / Publicación
Juárez Camacho, P., Fournier, P. G. J., Mohammad, K., McKenna, R., Davis, H., Peng, X., Niewolna, M., Mauviel, A., Chirgwin, J., & Guise, T. (2017). Halofuginone inhibits TGF-ß/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis. Oncotarget, 8(49), 86447-86462. doi: 10.18632/oncotarget.21200. (ID: 22561)
Fournier, P. G. J., Juárez Camacho, P., Jiang, G., Clines, G., Niewolna, M., Kim, H. S., Walton, H., Peng, X., Liu, Y., Mohammad, K., Wells, C., Chirgwin, J., & Guise, T. (2015). The TGF-ß Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone. CANCER CELL, 27(6), 809-821. doi: 10.1016/j.ccell.2015.04.009. (ID: 19179) (E)
Juárez Camacho, P. (2014). Plant-derived anticancer agents: a promising treatment for bone metastasis. BoneKEy Reports, 3(599), 1-8. doi: 10.1038/bonekey.2014.94. (ID: 18578)
Fournier, P. G. J., Juárez Camacho, P., & Guise, T. (2014). Tumor-bone interactions: there is no place like bone. In Dominique Heymann (Eds.), Bone Cancer - Primary Bone Cancers and Bone Metastases (2 ed.). Academic Press. (ID: 18148) (E)
Juárez Camacho, P. (2014). 13th International Conference on Cancer-Induced Bone Disease - Meeting report. IBMS BoneKEy, 11(516), 1-3. doi: 10.1038/bonekey.2014.11. (ID: 18577) (E)
Juárez Camacho, P., Mohammad, K., Yin, J. J., Fournier, P. G. J., McKenna, R., Davis, H., Peng, X., Niewolna, M., Javelaud, D., Chirgwin, J., Mauviel, A., & Guise, T. (2012). Halofuginone Inhibits the Establishment and Progression of Melanoma Bone Metastases. CANCER RESEARCH, 72(23), 6247-6256. doi: 10.1158/0008-5472.CAN-12-1444. (ID: 17656) (E)
Buijs, J. T., Juárez Camacho, P., & Guise, T. (2011). Therapeutic strategies to target TGF-ß in the treatment of bone metastases. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 12(12), 2121-2137. doi: 10.2174/138920111798808293. (ID: 18218) (E)
Juárez Camacho, P., & Guise, T. (2011). TGF-ß in cancer and bone: implications for treatment of bone metastases. BONE, 48(1), 23-29. doi: 10.1016/j.bone.2010.08.004. (ID: 18219) (E)
Alexaki, V., Javelaud, D., Van Kempen, L., Mohammad, K., Dennler, S., Luciani, F., Hoek, K., Juárez Camacho, P., Goydos, J., Fournier, P. G. J., Sibon, C., Bertolotto, C., Verrecchia, F., Saule, S., Delmas, V., Ballotti, R., Larue, L., Saiag, P., Guise, T., & Mauviel, A. (2010). GLI2-Mediated Melanoma Invasion and Metastasis. Journal of the National Cancer Institute, 102(15), 1148-1159. doi: 10.1093/jnci/djq257. (ID: 17660) (E)
Juárez Camacho, P., & Guise, T. (2010). TGF-Beta pathway as a therapeutic target in bone metastases. CURRENT PHARMACEUTICAL DESIGN, 16(11), 1301-1312. doi: 10.2174/138161210791034049. (ID: 18220) (E)
Ponce Coria, J., San Cristobal, P., Kahle, K. T., Vazquez, N., Pacheco Alvarez, D., De Los Heros, P., Juárez Camacho, P., Muñoz, E., Michel, G., Bobadilla, N. A., Gimenez, I., Lifton, R. P., Hebert, S. C., & Gamba, G. (2008). Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases. Proceedings of the National Academy of Sciences of the United States of America, 105(24), 8458-8463. doi: 10.1073/pnas.0802966105. (ID: 18221) (E)
Lopez Casillas, F., Vilchis Landeros, M., Esparza Lopez, J., Ponce Castañeda, M. V., Velasco Loyden, N. G., Juárez Camacho, P., Montiel, J. L., & Mendoza, V. (2008). Regulation of the Transforming Growth Factor-ß Superfamily by Betaglycan. In Sonia B. Jacowiew (Eds.), Transforming Growth Factor-ß in Cancer Therapy, Volumen I (1 ed., pp. 451-462). Humana Press. (ID: 18217) (E)
Hernandez, M., Cabrera Ponce, J. L., Fragoso, G., Lopez Casillas, F., Guevara Garcia, A., Rosas, G., Leon Ramirez, C., Juárez Camacho, P., Sanchez Garcia, G., Cervantes, J., Acero, G., Toledo, A., Cruz, C., Bojalil, R., Herrera Estrella, L., & Sciutto, E. (2007). A new highly effective anticysticercosis vaccine expressed in transgenic papaya. VACCINE, 25(21), 4252-4260. doi: 10.1016/j.vaccine.2007.02.080. (ID: 18222) (E)
Juárez Camacho, P., Vilchis Landeros, M., Ponce Coria, J., Mendoza, V., Bobadilla, N. A., Hernandez Pando, R., & Lopez Casillas, F. (2007). Soluble betaglycan reduces renal damage progression in db/db mice. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 292(1), F321-F329. doi: 10.1152/ajprenal.00264.2006. (ID: 18223) (E)
Vilchis Landeros, M. M., Juárez Camacho, P., & Lopez Casillas, F. (2003). El papel fisiopatológico del TGF-beta en las nefropatías de diversas etiologías: los inhibidores del TGF-beta como inhibidores terapéuticos potenciales. Gaceta Médica de México, 139(2), 126-134. (ID: 18225) (E)